J1580Garamycin gentamicin inj
Published CMS Medicare Part B payment-limit context for J1580, with recent quarterly history and calculated package-level strength context from the CMS crosswalk.
CMS payment limit
$1.925
per 80 MG · Medicare Part B
Down 0.2%from $1.928 in 2026-Q2
- Current quarter
- Billing unit
Payment limit over time
$2.8541$1.8109
2024-Q4: $2.74; 2025-Q1: $2.47; 2025-Q2: $2.467; 2025-Q3: $2.615; 2025-Q4: $2.208; 2026-Q1: $2.166; 2026-Q2: $1.928; 2026-Q3: $1.925
No current FDA shortage matchThe latest completed FDA data has no affected record matching the Gentamicin Sulfate ingredient family (FDA data as of August 20, 2026).
Gentamicin Sulfate
Package figures are calculated from the CMS per-unit payment limit × billable units per package; they are not CMS-published package-level payment limits.
Put another code on your radar.
Browse the CMS directory for published payment-limit context across drugs, NDCs, and source-backed HCPCS Level II drug codes.